2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol

C165H336F2N24O14 — CID 158681030

IUPAC2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol
SMILESCC(C)CCN1CC(=O)NC(C(C)C)C1.CC(C)CCN1CC(C(C)(C)O)C1.CC(C)CCN1CC(C)(O)C1.CC(C)CCN1CCC(C(C)(C)O)CC1.CC(C)CCN1CCC(C)(O)CC1.CC(C)CCN1CCC2(CC1)CC(O)C2.CC(C)CCN1CCN(C(C)(C)C(N)=O)CC1.CC(C)CCN1CCN(C(C)C)C(=O)C1.CC(C)CCN1CCN(C)CC1.CC(C)CCN1CCOC(C)(C)C1.CC(C)CN1CC(CN(C)C2CCOC2)C1.CC(C)CN1CC(F)(CN(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC(F)(CN(C)C2COC2)C1.CC(C)CN1CC(O)(CN(C)C2COC2)C1
InChIInChI=1S/C13H26FN3O.C13H27N3O.C13H26N2O.C13H25NO.C13H27NO.C12H23FN2O.C12H24N2O2.2C12H24N2O.3C11H23NO.C10H22N2.C9H19NO/c1-10(2)6-17-8-13(14,9-17)7-16(5)12(3,4)11(15)18;1-11(2)5-6-15-7-9-16(10-8-15)13(3,4)12(14)17;1-11(2)6-15-8-12(9-15)7-14(3)13-4-5-16-10-13;1-11(2)3-6-14-7-4-13(5-8-14)9-12(15)10-13;1-11(2)5-8-14-9-6-12(7-10-14)13(3,4)15;1-10(2)4-15-8-12(13,9-15)7-14(3)11-5-16-6-11;1-10(2)4-14-8-12(15,9-14)7-13(3)11-5-16-6-11;1-9(2)5-6-14-7-11(10(3)4)13-12(15)8-14;1-10(2)5-6-13-7-8-14(11(3)4)12(15)9-13;1-10(2)4-7-12-8-5-11(3,13)6-9-12;1-9(2)5-6-12-7-10(8-12)11(3,4)13;1-10(2)5-6-12-7-8-13-11(3,4)9-12;1-10(2)4-5-12-8-6-11(3)7-9-12;1-8(2)4-5-10-6-9(3,11)7-10/h10H,6-9H2,1-5H3,(H2,15,18);11H,5-10H2,1-4H3,(H2,14,17);11-13H,4-10H2,1-3H3;11-12,15H,3-10H2,1-2H3;11-12,15H,5-10H2,1-4H3;10-11H,4-9H2,1-3H3;10-11,15H,4-9H2,1-3H3;9-11H,5-8H2,1-4H3,(H,13,15);10-11H,5-9H2,1-4H3;10,13H,4-9H2,1-3H3;9-10,13H,5-8H2,1-4H3;10H,5-9H2,1-4H3;10H,4-9H2,1-3H3;8,11H,4-7H2,1-3H3
InChIKeyIFDALFMMMBBXDG-UHFFFAOYSA-N
MW2918.65 g/mol
LogP20.08
Rot. Bonds57

About 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol

2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol (PubChem CID 158681030) has the molecular formula C165H336F2N24O14 and a molecular weight of 2918.65 g/mol. Its IUPAC name is 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol.

Molecular Properties

Compound Name2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol
PubChem CID158681030
Molecular FormulaC165H336F2N24O14
Molecular Weight2918.65 g/mol
Exact Mass2916.63
IUPAC Name2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol
SMILESCC(C)CCN1CC(=O)NC(C(C)C)C1.CC(C)CCN1CC(C(C)(C)O)C1.CC(C)CCN1CC(C)(O)C1.CC(C)CCN1CCC(C(C)(C)O)CC1.CC(C)CCN1CCC(C)(O)CC1.CC(C)CCN1CCC2(CC1)CC(O)C2.CC(C)CCN1CCN(C(C)(C)C(N)=O)CC1.CC(C)CCN1CCN(C(C)C)C(=O)C1.CC(C)CCN1CCN(C)CC1.CC(C)CCN1CCOC(C)(C)C1.CC(C)CN1CC(CN(C)C2CCOC2)C1.CC(C)CN1CC(F)(CN(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC(F)(CN(C)C2COC2)C1.CC(C)CN1CC(O)(CN(C)C2COC2)C1
InChIInChI=1S/C13H26FN3O.C13H27N3O.C13H26N2O.C13H25NO.C13H27NO.C12H23FN2O.C12H24N2O2.2C12H24N2O.3C11H23NO.C10H22N2.C9H19NO/c1-10(2)6-17-8-13(14,9-17)7-16(5)12(3,4)11(15)18;1-11(2)5-6-15-7-9-16(10-8-15)13(3,4)12(14)17;1-11(2)6-15-8-12(9-15)7-14(3)13-4-5-16-10-13;1-11(2)3-6-14-7-4-13(5-8-14)9-12(15)10-13;1-11(2)5-8-14-9-6-12(7-10-14)13(3,4)15;1-10(2)4-15-8-12(13,9-15)7-14(3)11-5-16-6-11;1-10(2)4-14-8-12(15,9-14)7-13(3)11-5-16-6-11;1-9(2)5-6-14-7-11(10(3)4)13-12(15)8-14;1-10(2)5-6-13-7-8-14(11(3)4)12(15)9-13;1-10(2)4-7-12-8-5-11(3,13)6-9-12;1-9(2)5-6-12-7-10(8-12)11(3,4)13;1-10(2)5-6-12-7-8-13-11(3,4)9-12;1-10(2)4-5-12-8-6-11(3)7-9-12;1-8(2)4-5-10-6-9(3,11)7-10/h10H,6-9H2,1-5H3,(H2,15,18);11H,5-10H2,1-4H3,(H2,14,17);11-13H,4-10H2,1-3H3;11-12,15H,3-10H2,1-2H3;11-12,15H,5-10H2,1-4H3;10-11H,4-9H2,1-3H3;10-11,15H,4-9H2,1-3H3;9-11H,5-8H2,1-4H3,(H,13,15);10-11H,5-9H2,1-4H3;10,13H,4-9H2,1-3H3;9-10,13H,5-8H2,1-4H3;10H,5-9H2,1-4H3;10H,4-9H2,1-3H3;8,11H,4-7H2,1-3H3
InChIKeyIFDALFMMMBBXDG-UHFFFAOYSA-N
XLogP20.08
TPSA358.69 Ų
H-Bond Donors9
H-Bond Acceptors34
Rotatable Bonds57
Heavy Atoms205
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002918.65
LogP ≤ 520.08
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1034

Analyze 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol?
The IUPAC name of 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol (CID 158681030) is 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol.
What is the SMILES notation for 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol?
The canonical SMILES for 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol is CC(C)CCN1CC(=O)NC(C(C)C)C1.CC(C)CCN1CC(C(C)(C)O)C1.CC(C)CCN1CC(C)(O)C1.CC(C)CCN1CCC(C(C)(C)O)CC1.CC(C)CCN1CCC(C)(O)CC1.CC(C)CCN1CCC2(CC1)CC(O)C2.CC(C)CCN1CCN(C(C)(C)C(N)=O)CC1.CC(C)CCN1CCN(C(C)C)C(=O)C1.CC(C)CCN1CCN(C)CC1.CC(C)CCN1CCOC(C)(C)C1.CC(C)CN1CC(CN(C)C2CCOC2)C1.CC(C)CN1CC(F)(CN(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC(F)(CN(C)C2COC2)C1.CC(C)CN1CC(O)(CN(C)C2COC2)C1.
What is the InChIKey of 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol?
The InChIKey is IFDALFMMMBBXDG-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H26FN3O.C13H27N3O.C13H26N2O.C13H25NO.C13H27NO.C12H23FN2O.C12H24N2O2.2C12H24N2O.3C11H23NO.C10H22N2.C9H19NO/c1-10(2)6-17-8-13(14,9-17)7-16(5)12(3,4)11(15)18;1-11(2)5-6-15-7-9-16(10-8-15)13(3,4)12(14)17;1-11(2)6-15-8-12(9-15)7-14(3)13-4-5-16-10-13;1-11(2)3-6-14-7-4-13(5-8-14)9-12(15)10-13;1-11(2)5-8-14-9-6-12(7-10-14)13(3,4)15;1-10(2)4-15-8-12(13,9-15)7-14(3)11-5-16-6-11;1-10(2)4-14-8-12(15,9-14)7-13(3)11-5-16-6-11;1-9(2)5-6-14-7-11(10(3)4)13-12(15)8-14;1-10(2)5-6-13-7-8-14(11(3)4)12(15)9-13;1-10(2)4-7-12-8-5-11(3,13)6-9-12;1-9(2)5-6-12-7-10(8-12)11(3,4)13;1-10(2)5-6-12-7-8-13-11(3,4)9-12;1-10(2)4-5-12-8-6-11(3)7-9-12;1-8(2)4-5-10-6-9(3,11)7-10/h10H,6-9H2,1-5H3,(H2,15,18);11H,5-10H2,1-4H3,(H2,14,17);11-13H,4-10H2,1-3H3;11-12,15H,3-10H2,1-2H3;11-12,15H,5-10H2,1-4H3;10-11H,4-9H2,1-3H3;10-11,15H,4-9H2,1-3H3;9-11H,5-8H2,1-4H3,(H,13,15);10-11H,5-9H2,1-4H3;10,13H,4-9H2,1-3H3;9-10,13H,5-8H2,1-4H3;10H,5-9H2,1-4H3;10H,4-9H2,1-3H3;8,11H,4-7H2,1-3H3.
What are the key properties of 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol?
2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol has a molecular weight of 2918.65 g/mol, XLogP of 20.08, 57 rotatable bonds, 9 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 2,2-dimethyl-4-(3-methylbutyl)morpholine;2-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;N-[[3-fluoro-1-(2-methylpropyl)azetidin-3-yl]methyl]-N-methyloxetan-3-amine;7-(3-methylbutyl)-7-azaspiro[3.5]nonan-2-ol;2-[1-(3-methylbutyl)azetidin-3-yl]propan-2-ol;2-[1-(3-methylbutyl)piperidin-4-yl]propan-2-ol;4-(3-methylbutyl)-1-propan-2-ylpiperazin-2-one;4-(3-methylbutyl)-6-propan-2-ylpiperazin-2-one;3-methyl-1-(3-methylbutyl)azetidin-3-ol;1-methyl-4-(3-methylbutyl)piperazine;2-methyl-2-[4-(3-methylbutyl)piperazin-1-yl]propanamide;4-methyl-1-(3-methylbutyl)piperidin-4-ol;N-methyl-N-[[1-(2-methylpropyl)azetidin-3-yl]methyl]oxolan-3-amine;3-[[methyl(oxetan-3-yl)amino]methyl]-1-(2-methylpropyl)azetidin-3-ol is sourced from PubChem (CID 158681030), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).